Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Stupid question about abyss

    Hi, all,

    I have 100 bp pe reads from Hiseq for target genes with size around 200bp. I tried abyss to de novo assemble them.

    I used k=40, n=10. When I compared the contigs and the reference sequence, which I used as positive control, I found that there were many small contigs overlapping each other by more than 50bp. Why abyss didn't assemble them into a longer contig? After I increase the k to 60, I saw longer contigs, but there were still overlapping but separate contigs. I am naive to the de bruijn graph and have no ideas about how abyss works. What can I do to get longer contigs instead of shot overlapping ones. Should I increase k more or change the n parameter.

    Another question, when I used k=60, did I excluded all reads that are shorter than 60 bp from analysis?

    Thanks in advance for your help.

  • #2
    Originally posted by cli View Post
    I am naive to the de bruijn graph and have no ideas about how abyss works.
    Have you looked at the ABySS listserve (https://groups.google.com/forum/?hl=...um/abyss-users). A wealth of info there that you may find useful.

    Comment


    • #3
      I also highly recommend taking your questions to the ABySS user group. The developers are quite on top of answering questions.

      However, I can tell you it would helpful to know what commands including all the options you used. It sounds to me like you might have just done the initial step (the ABYSS step which is the SE assembly only). That's fine to start with, but you should also continue down the assembly pipeline using abyss-pe. Many of the next steps will merge these overlapping contigs.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Current Approaches to Protein Sequencing
        by seqadmin


        Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
        04-04-2024, 04:25 PM
      • seqadmin
        Strategies for Sequencing Challenging Samples
        by seqadmin


        Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
        03-22-2024, 06:39 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, 04-11-2024, 12:08 PM
      0 responses
      25 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-10-2024, 10:19 PM
      0 responses
      27 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-10-2024, 09:21 AM
      0 responses
      24 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 04-04-2024, 09:00 AM
      0 responses
      52 views
      0 likes
      Last Post seqadmin  
      Working...
      X